(Q51932053)
Statements
Pharmacokinetics of 5,6-dimethylxanthenone-4-acetic acid (AS1404), a novel vascular disrupting agent, in phase I clinical trial. (English)
1 reference
M B Jameson
1 reference
B C Baguley
1 reference
P Kestell
1 reference
L Zhao
1 reference
P I Thompson
1 reference
S Waller
1 reference
Cancer Research (UK) Phase I/II Trials Committee
1 reference
23 September 2006
1 reference
59
1 reference
5
1 reference
681-687
1 reference